FILING ANALYSIS · MONDAY, SEPTEMBER 28
BIOMERICA INC BMRA — 10-K/A
neutral
This 10-K/A filing appears to be a routine update with no significant surprises or quantified disclosures that would impact the stock price, and the company's governance and executive team remain unchanged.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →